Global Health Clinics Ltd. (CSE:MJRX.X)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Aug 24, 2026, 9:41 AM EST
Global Health Clinics Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Revenue | 0.01 | 0.05 | 0.08 | 0.1 | 0.15 | 0.23 |
Revenue Growth | -78.90% | -42.42% | -19.34% | -29.94% | -34.78% | -36.08% |
Cost of Revenue | 0 | 0 | 0.02 | 0.02 | 0.03 | 0.05 |
Gross Profit | 0.01 | 0.04 | 0.06 | 0.08 | 0.12 | 0.18 |
Selling, General & Admin | 1.07 | 1.08 | 1 | 1.63 | 1.52 | 1.31 |
Research & Development | - | - | - | - | 0.01 | 0.04 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 0.13 |
Operating Expenses | 1.07 | 1.08 | 1 | 1.63 | 1.53 | 6.01 |
Operating Income | -1.06 | -1.03 | -0.94 | -1.55 | -1.42 | -5.83 |
Interest Expense | -0.43 | -0.21 | -0.13 | -0.05 | -0.01 | -0 |
Interest & Investment Income | - | - | 0 | - | - | 0 |
Other Non Operating Income (Expenses) | 0.13 | -0.02 | -0.02 | -0.02 | 0.06 | -0.05 |
EBT Excluding Unusual Items | -1.36 | -1.27 | -1.08 | -1.63 | -1.37 | -5.88 |
Asset Writedown | - | - | - | - | - | -2.51 |
Legal Settlements | - | - | - | - | - | -0.09 |
Other Unusual Items | 0 | - | 0 | 0 | -0 | - |
Pretax Income | -1.36 | -1.27 | -1.08 | -1.63 | -1.37 | -8.48 |
Net Income | -1.36 | -1.27 | -1.08 | -1.63 | -1.37 | -8.48 |
Net Income to Common | -1.36 | -1.27 | -1.08 | -1.63 | -1.37 | -8.48 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 |
Shares Change | - | - | - | 150.82% | 77.50% | 575.42% |
EPS (Basic) | -1.30 | -1.21 | -1.03 | -1.56 | -3.29 | -36.17 |
EPS (Diluted) | -1.30 | -1.21 | -1.03 | -1.56 | -3.29 | -36.17 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -0.57 | -0.57 | -0.5 | -1.01 | -1.49 | -0.83 |
Free Cash Flow Per Share | -0.55 | -0.55 | -0.48 | -0.97 | -3.58 | -3.52 |
Gross Margin | 67.99% | 93.17% | 77.00% | 78.40% | 79.01% | 78.97% |
Operating Margin | -8088.51% | -2159.57% | -1127.39% | -1508.56% | -963.98% | -2591.48% |
Profit Margin | -10385.67% | -2648.84% | -1299.62% | -1580.10% | -932.61% | -3766.82% |
Free Cash Flow Margin | -4391.71% | -1197.81% | -598.52% | -981.81% | -1014.11% | -366.87% |
EBITDA | -1.06 | -1.03 | -0.93 | -1.55 | -1.41 | -5.83 |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.06 | -1.03 | -0.94 | -1.55 | -1.42 | -5.83 |
Advertising Expenses | - | - | - | 0.59 | 0.44 | - |